Henry Pelish
Förmögenhet: 7 M $ per 2026-05-31
Förmögenhet: 7 M $ per 2026-05-31
Dr. Henry Pelish is a Chief Scientific Officer at Nuvalent, Inc. Dr. Pelish was previously employed as a Research Associate by Harvard University.
He received his undergraduate degree from The Johns Hopkins University, a graduate degree from Stanford University and a doctorate degree from Harvard University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,09 % | 2026-04-09 | 65 604 ( 0,09 % ) | 7 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| NUVALENT, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-07-11 |
| Företag | Position | Slut |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån